The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology

Introduction: Pamrevlumab, a monoclonal antibody targeting CTGF, is considered a potential therapy for eye diseases involving fibrosis. The aim of this study was to explore its potential in treating eye diseases. Methods: A systematic review was conducted following PRISMA guidelines, searc...

Full description

Saved in:
Bibliographic Details
Main Authors: Lely Retno Wulandari, Edwin Damar Prabowo, Happy Kurnia Permata Sari, Hidayat Sujuti, Sri Winarsih
Format: Article
Language:English
Published: Pensoft Publishers 2025-06-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/144964/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items